In prostate tissue, high expression of IGF-I and its receptor is considered to be closely related to the occurrence and progression of prostate cancer, and some genetic variations (such as SNPs in the 3’UTR region of IGF1R) may also regulate IGF-I signaling by affecting miRNA binding, thereby changing individual susceptibility (3). The gene discussed is IGF1; the disease is prostate carcinoma.